results of a phase ii study of lhrh therapy in high-risk prostate cancer
Published 6 years ago • 108 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:18
results of the latitude trial in high-risk metastatic hormone-naive prostate cancer
-
8:23
results from a phase i study of amg 160
-
1:40
dr. koontz discusses lhrh in high-risk prostate cancer
-
1:27
a new standard of care - improving prostate cancer cure rates in high-risk patients
-
14:14
trials in neoadjuvant therapy for patients with high-risk localized prostate cancer
-
7:58
hormone therapy side effect solutions: exercise, acupuncture, and more | mark moyad, md | pcri
-
5:11
hormone therapy for high-risk prostate cancer | prostate cancer staging guide
-
1:12
dr. kearns on the role of surgery in high-risk prostate cancer
-
5:29
overview of azure (high-risk) prostate cancer | prostate cancer staging guide
-
3:54
combination therapy for high-risk, hormone therapy duration for intermediate-risk | yt comments #28
-
5:32
understanding treatment for high-risk prostate cancer | prostate cancer staging guide
-
30:17
prostate cancer, treatment, and clinical trials: expert q&a
-
5:54
high-risk prostate cancer: benefit to adding 2nd generation hormone therapy or chemo? | pcri
-
7:25
optimizing androgen deprivation therapy in high-risk prostate cancer
-
4:59
intermittent hormone therapy: psa and hormone replacement | ask a prostate expert, mark scholz, md
-
12:43
maximizing results: 1st & 2nd generation hormone therapy from the outset? #markscholzmd #alexscholz
-
12:30
long term morbidity mortality of adt and radiation therapy
-
34:43
prostate cancer: evaluation and management of low risk disease
-
9:32
high risk prostate cancer: surgery vs. radiation | genomic tests | mark scholz, md | pcri